Key research & article

Total hit(s): 73

S.No.
1	33713730	Combined in silico and in vitro approaches identified the antipsychotic drug lurasidone and the antiviral drug elbasvir as SARS-CoV2 and HCoV-OC43 inhibitors	Antiviral Res	2021 May	4.12
2	33825201	Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS-CoV-2 infection in vitro	Br J Pharmacol	2021 Apr 6	6.48
3	33917313	Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods	Pharmaceuticals (Basel)	2021 Apr 6
4	33910954	Inhibitors of coronavirus 3CL proteases protect cells from protease-mediated cytotoxicity	J Virol	2021 Apr 28	4.16
5	33932547	Astemizole as a drug to inhibit the effect of SARS-COV-2 in vitro	Microb Pathog	2021 Apr 28	2.64
6	33903110	Overcoming culture restriction for SARS-CoV-2 in human cells facilitates the screening of compounds inhibiting viral replication	Antimicrob Agents Chemother	2021 Apr 26	4.68
7	33907750	Multidose evaluation of 6,710 drug repurposing library identifies potent SARS-CoV-2 infection inhibitors In Vitro and In Vivo	bioRxiv	2021 Apr 22	Its not a journal
8	33880524	In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19	J Antimicrob Chemother	2021 Apr 21	4.94
9	33821265	Discovery and in-vitro evaluation of potent SARS-CoV-2 entry inhibitors	bioRxiv	2021 Apr 2	Its not a journal
10	33919584	Bromodomain and Extraterminal Protein Inhibitor, Apabetalone (RVX-208), Reduces ACE2 Expression and Attenuates SARS-Cov-2 Infection In Vitro	Biomedicines	2021 Apr 18
11	33686143	The in-vitro effect of famotidine on sars-cov-2 proteases and virus replication	Sci Rep	2021 Mar 8	4.12
12	33688653	Blockade of SARS-CoV-2 infection in vitro by highly potent PI3K-α/mTOR/BRD4 inhibitor	bioRxiv	2021 Mar 5	Its not a journal
13	33806331	Repurposing of Some Natural Product Isolates as SARS-COV-2 Main Protease Inhibitors via In Vitro Cell Free and Cell-Based Antiviral Assessments and Molecular Modeling Approaches	Pharmaceuticals (Basel)	2021 Mar 4
14	33862474	Novel inhibitors of the main protease enzyme of SARS-CoV-2 identified via molecular dynamics simulation-guided in vitro assay	Bioorg Chem	2021 Mar 29	3.94
15	33791693	Phospholipidosis is a shared mechanism underlying the in vitro antiviral activity of many repurposed drugs against SARS-CoV-2	bioRxiv	2021 Mar 24	Its not a journal
16	33759449	Drugs in COVID-19 Clinical Trials: Predicting Transporter-Mediated Drug-Drug Interactions Using In Vitro Assays and Real-World Data	Clin Pharmacol Ther	2021 Mar 24	5.26
17	33778258	Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: In Vitro Activity against SARS-CoV-2 and Potential Mechanisms	ACS Omega	2021 Mar 23	2.55
18	33732940	Discovery of Clioquinol and analogues as novel inhibitors of Severe Acute Respiratory Syndrome Coronavirus 2 infection, ACE2 and ACE2 - Spike protein interaction in vitro	Heliyon	2021 Mar	1.65
19	33558299	AT-527, a Double Prodrug of a Guanosine Nucleotide Analog, Is a Potent Inhibitor of SARS-CoV-2 In Vitro and a Promising Oral Antiviral for Treatment of COVID-19	Antimicrob Agents Chemother	2021 Feb 8	4.68	1
20	33558781	Toward the understanding of national culture in the success of non-pharmaceutical technological interventions in mitigating COVID-19 pandemic	Ann Oper Res	2021 Feb 3		1
21	33637768	A SARS-CoV-2 cytopathicity dataset generated by high-content screening of a large drug repurposing collection	Sci Data	2021 Feb 26	6.46	1
22	33622090	Remdesivir for the Treatment of COVID-19: A Need for Combined In Vivo and In Vitro Studies to Evaluate the Efficacy	J Pharm Pract	2021 Feb 24		1
23	33568500	Reply to Ma and Wang: Reliability of various in vitro activity assays on SARS-CoV-2 main protease inhibitors	Proc Natl Acad Sci U S A	2021 Feb 23	9.35	1
24	33538596	Targeting SARS-CoV-2 M3CLpro by HCV NS3/4a Inhibitors: In Silico Modeling and In Vitro Screening	J Chem Inf Model	2021 Feb 22	4.04	1
25	33619486	Probing the SAM Binding Site of SARS-CoV-2 nsp14 in vitro Using SAM Competitive Inhibitors Guides Developing Selective bi-substrate Inhibitors	bioRxiv	2021 Feb 19	Its not a journal	1